Epic Drug Scandal

Scott Gottlieb, M.D., former Deputy Commissioner at the Food and Drug Administration (FDA) and resident fellow at the American Enterprise Institute, describes how the FDA’s narrowly prescriptive generic drug approval process creates expensive barriers to market entry that led to the EpiPen drug pricing debacle.

Download From iTunes Watch